Measles attenuated live vaccine

The Measles attenuated live vaccine, developed by the Institute of Medical Biology at the Chinese Academy of Medical Sciences (IMB-CAMS), is a viral vaccine indicated for the prevention of measles. It is typically based on the L-16 strain, which has been widely used in China's national immunization program. In the provided clinical context, this vaccine is mentioned in relation to hand, foot, and mouth disease (HFMD) due to a Phase 4 clinical trial (NCT02839109) evaluating the safety and immunogenicity of its co-administration with an inactivated Enterovirus 71 (EV71) vaccine in 8-month-old infants. The study aims to ensure that simultaneous administration of the routine measles vaccine and the EV71 vaccine does not result in immune interference or increased adverse events.

Other names

measles attenuated live vaccine-Chinese Academy of Medical Sciences-hand, foot and mouth diseaseL-16 strain measles vaccineL16 strain measles vaccineL 16 strain measles vaccineMeasles vaccine (IMB-CAMS)